Alnylam Pharmaceuticals
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Massachusetts, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
675 W Kendall St # A, Cambridge, Massach...Phone Number
(617) 551-8200Website
www.alnylam.comRevenue
$4.8 BillionStock Symbol
ALNYIndustry
About Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a pioneering biopharmaceutical company specializing in RNA interference (RNAi) therapeutics, which offer a novel approach to treating diseases by silencing the genes responsible for them. The company is dedicated to developing transformational medicines aimed at benefiting patients with both rare and prevalent diseases across various therapeutic areas. Alnylam is committed to scientific innovation and corporate responsibility, striving to make a positive impact beyond its medicinal offerings. Their focus on patient-centered care drives their mission to push the boundaries of RNAi science.Explore more
Alnylam Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Alnylam Pharmaceuticals
Compare insights from companies similar to Alnylam Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$12.6B
5K - 10K
Public
$2.5B
1989
GL
Gina LaCorciaVice President, Chief of Staff To the CEO and Head of the Disease Strategy Team Program Office
Alnylam Pharmaceuticals Tech Stack
A closer look at the technologies used by Alnylam Pharmaceuticals
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Alnylam Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Alnylam Pharmaceuticals is a pioneering biopharmaceutical company specializing in RNA interference (RNAi) therapeutics, which offer a novel approach to treating diseases by silencing the genes responsible for them. The company is dedicated to developing transformational medicines aimed at benefiting patients with both rare and prevalent diseases ac... Read More
